Financhill
Back

Ikena Oncology Quote, Financials, Valuation and Earnings

Ikena Oncology Price Quote

$1.69
+0.01 (+0.9%)
(Updated: November 20, 2024 at 4:18 AM ET)

Ikena Oncology Key Stats

Sell
36
Ikena Oncology (IKNA) is a Sell

Day range:
$1.66 - $1.70
52-week range:
$1.22 - $2.32
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.81
P/B ratio:
0.6%

Volume:
54.8K
Avg. volume:
56.7K
1-year change:
-6.67%
Market cap:
$80.8M
Revenue:
$9.2M
EPS:
$-1.22

How Much Does Ikena Oncology Make?

Data Unavailable

Is Ikena Oncology Growing As A Company?

Data Unavailable

Ikena Oncology Stock Price Performance

  • Did Ikena Oncology Stock Go Up Last Month?
    Ikena Oncology share price went down by -1.75% last month
  • Did IKNA's Share Price Rise Over The Last Year?
    IKNA share price fell by -6.67% over the past 1 year

What Is Ikena Oncology 52-Week High & Low?

Ikena Oncology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ikena Oncology?

  • How Much Debt Does Ikena Oncology Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Ikena Oncology Have?
    Cash and short term investments quarterly total is $138M
  • What Is Ikena Oncology’s Book Value Per Share?
    Book value per share is 2.78

Is Ikena Oncology Cash Flow Positive?

  • What Is IKNA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$61.6M
  • What Is Ikena Oncology’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Ikena Oncology’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$15M

Ikena Oncology Return On Invested Capital

Data Unavailable

Ikena Oncology Earnings Date & Stock Price

Ikena Oncology Competitors

  • Who Are Ikena Oncology's Competitors?
    Below is a list of companies who compete with Ikena Oncology or are related in some way:
    • iBio Inc (IBIO)
    • MediciNova Inc (MNOV)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Ikena Oncology Dividend Yield

Ikena Oncology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 29.02%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 3.00
Upside from Last Price: 78.57%

Major Shareholders

  • How many IKNA shares are owned by institutional investors?
    33.8M IKNA shares are owned by institutional investors
  • How many IKNA shares are owned by insiders?
    145.1K IKNA shares are owned by insiders